Abstract
Addendum: Effects of a 5-HT1B Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place Preference after Abstinence from Repeated Injections in Mice.
Highlights
Allen Institute for Brain Science Seattle, WA, United States Samuel J
The authors have identified a discrepancy between the 15 mg/kg, IP cocaine priming dose used in this study, and the IACUC approved protocol dose of 10 mg/kg, IP
The dose of 15 mg/kg, IP cocaine used for the repeated drug injections in this study is correct and approved in the same IACUC protocol and caused no pain or discomfort to mice
Summary
Received: 21 August 2018 Accepted: 24 September 2018 Published: 07 November 2018 (2018) Addendum: Effects of a 5-HT1B Receptor Agonist on Locomotion and Reinstatement of Cocaine-Conditioned Place
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have